Global Disposable Endoscopes Market Outlook
Revenue, 2024
$894M
Forecast, 2034
$6.37B
CAGR, 2025 - 2034
21.7%
The Disposable Endoscopes industry revenue is expected to be around $1087.6 million in 2025 and expected to showcase growth with 21.7% CAGR between 2025 and 2034. This trajectory reflects the growing centrality of disposable endoscopes in endoscopy services, as hospitals and ambulatory surgical centers now account for 88.2% of utilization, underpinned by stricter infection control standards, pressure to reduce capital intensive reprocessing infrastructure, and the need for predictable, per procedure costs; within this landscape, GI endoscopes lead adoption, generating $342.29 million in revenue in 2024 and reinforcing the modalitys role as a frontline option for high throughput diagnostic and therapeutic workflows, while healthcare providers increasingly value the operational resilience, rapid room turnover, and reduced cross contamination risk associated with these devices
The pre sterilized disposable endoscope system provides advanced imaging capabilities with flexible steerable shafts and plug and play connectivity for sterile visualization during various minimally invasive procedures in gastroenterology and pulmonology and urology and ENT interventions in hospital and clinic environments. The increasing adoption of single use endoscopes leads to their use in diagnostic procedures and emergency situations and situations that require maximum infection protection for patients. The market shows increasing interest from ambulatory surgical centers and standardization of procedures and continuous development of endoscope optics and ergonomics and workflow optimization.
Market Key Insights
The Disposable Endoscopes market will expand from $893.7 million in 2024 to reach $6.37 billion during the period from 2024 to 2034. The market will experience 21.7% annual growth because of increasing demand for Urology Procedures and Bronchoscopy Procedures and Gastroenterology Diagnostics.
Ambu A/S, Boston Scientific, and Karl Storz SE & Co. KG are among the leading players in this market, shaping its competitive landscape.
The Disposable Endoscopes market depends on the United States and China as its leading customer bases which will experience CAGR growth rates of 20.8% to 30.4% from 2024 to 2030.
The market research predicts that India, Brazil and South Korea will experience the highest growth rates at 16.3% to 22.6% CAGR.
Transition like Shift To Single-Use Models is expected to add $540 million to the Disposable Endoscopes market growth by 2030
.The Disposable Endoscopes market will experience $5.5 billion growth during 2024 to 2034 while manufacturers focus on expanding Bronchoscopy & ENT Application Application for increased market dominance.
With
escalating infection prevention mandates and rising awareness of cross-contamination risks accelerating shift to disposable endoscopes, and
Advances in imaging sensors and integrated digital platforms enhancing clinical performance of disposable endoscopes, Disposable Endoscopes market to expand 613% between 2024 and 2034.
Opportunities in the Disposable Endoscopes
The increasing need for infection prevention and ventilator associated pneumonia protocols drives hospitals to replace their reusable bronchoscopes with disposable endoscopes for critical care patients. The single use endoscopes in intensive care units provide complete contamination protection while simplifying sterilization procedures and guaranteeing immediate device access. The majority of community hospitals lack subscription based bronchoscopy programs which hospitals establish with manufacturers for their bronchoscopy needs. The global market for disposable bronchoscopes will also expand from 236.83 million to 808.17 million during the 2030 period which positions bronchoscopes as the leading disposable endoscopy segment in hospitals worldwide.
Growth Opportunities in North America and Asia-Pacific
The majority of North American acute care hospitals depend on disposable endoscopes because they perform complex gastrointestinal endoscopy and bronchoscopy and urology endoscopy procedures while following strict infection prevention guidelines. The main business potential exists in hospitals with mixed equipment and high volume ambulatory surgical centers that should adopt single use endoscopes for respiratory and ICU and emergency care to decrease contamination risks and enhance operating room efficiency. The market competition remains intense because multinational companies and specialized niche businesses compete through their expanded procedural offerings and digital reporting integration and group purchasing organization value based contracts. The market competition for endoscope differentiation has shifted toward demonstrating scientific proof about infection reduction and operational expenses that outperform traditional reprocessing systems. The market demand for endoscopes increases because of rising minimally invasive procedures and the need to reduce sterile processing department staff requirements and the development of outpatient endoscopy facilities that require dependable sterile endoscopy solutions.
The Asia Pacific region depends on its large tertiary and secondary hospitals to purchase disposable endoscopes because of rising medical procedures and better healthcare access and different infection control approaches between nations. The market demands two different product lines which should match different customer spending levels to serve metropolitan region's with premium single use endoscopes and public facilities and secondary cities with affordable models. The market competition involves established worldwide companies and new local manufacturers who use domestic manufacturing to compete through affordable prices and national regulatory benefits. The company needs to establish partnerships with hospital organizations and distribution networks to achieve formulary approval and secure extended agreements. The market experiences rapid growth because of rising minimally invasive procedure usage and flexible endoscopy infection control emphasis following COVID 19 and hospital construction for new facilities and outpatient endoscopy departments and doctor preference for simple devices that enable flexible procedure expansion.
Market Dynamics and Supply Chain
01
Driver: Escalating infection prevention mandates and rising awareness of cross contamination risks accelerating shift to disposable endoscopes
Healthcare providers now use disposable endoscopes because strict global infection control rules and hospital acquired infection penalty systems aim to stop reprocessing mistakes and biofilm contamination during high risk gastrointestinal and urology procedures. Healthcare organizations now choose single use endoscopes because they deliver dependable sterility tracing without needing complicated manual cleaning procedures or expensive sterilization systems. The increasing number of cross contamination incidents has also made healthcare providers and patients choose medical devices which completely remove all biological contaminants from use especially when treating immunocompromised patients in intensive care units. The combination of regulatory requirements and patient safety concerns has also led hospitals and ambulatory surgery centers to review their endoscope mix and boost their use of disposable endoscopes for protecting their brand image and enhancing endoscopy operational performance.
The development of compact high resolution imaging sensors and LED illumination systems and embedded electronics has also made disposable endoscopes achieve image quality comparable to reusable systems at affordable prices. The single use endoscope manufacturers have also developed plug and play digital platforms which include cloud based documentation and video recording capabilities for easy integration into current endoscopy suites and tele endoscopy systems. The technological integration enables immediate medical choices and enables distance learning and remote medical expertise while minimizing equipment breakdown time which makes advanced disposable endoscopes more desirable for precise medical diagnosis and small scale surgical procedures.
02
Restraint: Slow clinician adoption due to performance perceptions compared with reusable systems constrains disposable endoscopes penetration
The belief that reusable devices deliver better image quality and ergonomic design and reliability functions prevents endoscopists from adopting disposable endoscopes and single use endoscopes even though these devices provide superior infection control benefits. Gastroenterology units reserve disposable systems for high risk infection cases which restricts their use for other procedures and reduces market revenue because they continue to invest in reusable platforms.
03
Opportunity: Rapid expansion of disposable GI endoscopes in ambulatory surgical centers across Asia Pacific and Growing adoption of disposable urology and cystoscopes in outpatient clinics serving aging populations
The Asia Pacific region sees increasing adoption of disposable endoscopes because cancer screening programs expand and middle class people become more aware of their health needs. The adoption of single use GI endoscopes by ambulatory surgical centers occurs because these facilities want to reduce hospital acquired infections and shorten their equipment turnover periods and support minimally invasive surgical procedures. Mid tier healthcare providers who use multiple suppliers for their equipment needs and refurbished medical devices will benefit from complete service solutions. The worldwide disposable endoscopy market will experience its largest growth through GI endoscope sales which will expand from 342.29 million to 1274.70 million during the 2030 period.
The growing number of elderly patients with benign prostatic hyperplasia and bladder cancer requires more cystoscopy procedures in office based urology settings. Outpatient clinics select disposable endoscopes because they eliminate the need for reprocessing areas and reduce procedure delays and create uniform image quality between facilities. The integration of urology networks with telehealth diagnostic systems creates new opportunities for single use medical devices to perform immediate diagnostic tests. The global market for urology endoscopes will expand from 150.14 million to 430.68 million while cystoscopes will grow from 63.45 million to 176.59 million by 2030 at a faster rate than other medical specialties.
04
Challenge: High per procedure costs and reimbursement uncertainty limit large scale procurement of disposable endoscopes globally
The hospital procurement teams remain cautious because of high procedure costs and insufficient payment methods which limits disposable endoscope use to only emergency and intensive care bronchoscopy procedures thus reducing total market demand. The market competition between manufacturers becomes more intense because they need to maintain prices low while dealing with fully depreciated reusable equipment and increasing medical waste sustainability issues.
Supply Chain Landscape
1
Endoscopy Components Supply
Olympus CorporationKarl Storz SE & Co. KGBoston Scientific Corporation
2
Disposable Endoscope Production
Ambu A/SBoston Scientific CorporationOlympus Corporation
3
Single-use Endoscopes Distribution
Cook MedicalBoston Scientific CorporationOlympus Corporation
4
Clinical End Users
HospitalsAmbulatory Surgical CentersGastroenterology Clinics
1
Endoscopy Components Supply
Olympus CorporationKarl Storz SE & Co. KGBoston Scientific Corporation
2
Disposable Endoscope Production
Ambu A/SBoston Scientific CorporationOlympus Corporation
3
Single-use Endoscopes Distribution
Cook MedicalBoston Scientific CorporationOlympus Corporation
4
Clinical End Users
HospitalsAmbulatory Surgical CentersGastroenterology Clinics
Use Cases of Disposable Endoscopes in Urology Procedures & Bronchoscopy Procedures
Urology Procedures : The medical field of urology depends on disposable endoscopes which function as digital flexible ureteroscopes and cystoscopes for stone management and tumor surveillance and other minimally invasive procedures in hospitals and ambulatory surgical centers and high volume clinics. The 16.8% market share of urology endoscopes in 2024 enables precise visualization for stone management and tumor surveillance and other minimally invasive procedures in hospitals and ambulatory surgical centers and high volume clinics. The single use design of these instruments provides better urinary tract infection control because it prevents cross contamination and eliminates the requirement for complex reprocessing procedures which benefits ambulatory surgical centers that generated USD 284.20 million in 2024 and expect 24.4% annual growth until 2030. Ambu A/S leads the market for disposable cystoscopes and ureteroscopes through their development of user friendly visualization systems which integrate all necessary functions. Boston Scientific Corporation uses its stone management portfolio and digital ureteroscope technology to expand its urology endoscopy market presence. The urological imaging and tower systems market leaders Karl Storz SE & Co. KG and Olympus Corporation support a combination of reusable and disposable endoscopes through their established brand equity. Cook Medical supports their urology disposable product line with multiple access solutions which help hospitals and clinics reduce their reprocessing expenses.
Bronchoscopy Procedures : The use of disposable endoscopes for bronchoscopy continues to expand at a rapid pace because hospitals and ICUs now use bronchoscopes for 26.5% of their procedures to perform bedside airway assessments and secretion management and bronchoalveolar lavage. The immediate availability of single use endoscopes combined with their strong infection control features makes them suitable for ventilated and immunocompromised patients because they prevent cross contamination and eliminate the need for reprocessing and scope turnaround time. The main consumers of disposable bronchoscopes are hospitals which generated USD 504.05 million in disposable endoscope revenue during 2024 while showing 20.4% annual growth rate. The growing number of ambulatory surgical centers establishes pulmonary programs through disposable endoscopes because these facilities want flexible staffing and stable procedure costs. The market recognizes Ambu A/S as the leading company for disposable bronchoscopes because their complete aScope line with built in monitors delivers superior image quality and operational efficiency to critical care region's and operating rooms. Boston Scientific Corporation develops advanced disposable bronchoscopes which operate at high performance levels for ICU and OR environments. The two companies Olympus Corporation and Karl Storz SE & Co. KG use their established visualization systems and medical professional connections to help healthcare facilities adopt disposable bronchoscopes instead of traditional reusable models. Cook Medical provides hospitals and advanced respiratory clinics with additional pulmonary accessories and digital therapeutic devices which improve disposable bronchoscope functionality during complex minimally invasive procedures.
Gastroenterology Diagnostics : The market demand for disposable endoscopes shows gastroenterology as its leading segment because GI endoscopes represent 38.3% of the 2024 market share due to healthcare providers adopting disposable duodenoscopes and cholangioscopes and new disposable gastroscopes and colonoscopes for risky diagnostic and therapeutic procedures. The disposable GI endoscopes provide special benefits for complex medical procedures including ERCP because they eliminate the infection risks from reusable duodenoscope elevator mechanisms while hospitals aim to improve infection control and achieve stable equipment lifecycle and reprocessing expenses. The disposable GI endoscope market experiences above 22% annual growth because ambulatory surgical centers and clinics together generated $360 million in 2024 revenue and will continue to expand their use of advanced gastrointestinal diagnostics through disposable endoscopes without needing capital investments or specialized reprocessing facilities. Boston Scientific Corporation leads the GI endoscopy market through its leading disposable duodenoscope and cholangioscopy systems which integrate with its therapeutic solutions for pancreatobiliary disease to deliver superior results in high value procedures. Ambu A/S expands its GI endoscopy business through user friendly disposable GI systems which simplify medical procedures for both hospital and ambulatory surgical center staff. Olympus Corporation supports its existing customer base through its leading imaging technologies and wide range of GI accessories to guide customers toward disposable endoscope adoption. The company Karl Storz SE & Co. KG provides high performance GI visualization systems which support both reusable and disposable scopes to help providers achieve maximum clinical results and cost efficiency. Cook Medical expands its position in gastroenterology through its delivery of essential therapeutic devices including stents and dilatation systems and hemostasis tools which doctors use during complex gastrointestinal procedures with disposable endoscopes.
Impact of Industry Transitions on the Disposable Endoscopes Market
As a core segment of the Medical Device industry,
the Disposable Endoscopes market develops in line with broader industry shifts.
Over recent years, transitions such as Shift To Single Use Models and Digital Integration And New Settings have redefined priorities
across the Medical Device sector,
influencing how the Disposable Endoscopes market evolves in terms of demand, applications and competitive dynamics.
These transitions highlight the structural changes shaping long-term growth opportunities.
01
Shift To Single Use Models
The healthcareindustry'sshift towards disposable endoscopes is set to revolutionize procurement and operational strategies, with an anticipated market growth of $469 million by 2030. This transition eliminates the need for reprocessing, significantly reducing infection control risks and alleviating staff workloads, while also removing the necessity for sterilization facilities. As manufacturers pivot their research and development investments from durable medical devices to scalable disposable products, distributors must adapt their logistics to accommodate increased volumes at lower price points. This transformation not only reshapes service delivery and product maintenance across the gastroenterology sector but also underscores a strategic realignment in capital allocation and operational efficiencies, positioning companies to meet evolving market demands effectively. This industry transition is expected to add $540 million in the industry revenue between 2024 and 2030.
02
Digital Integration And New Settings
The development of imaging technology and sensors and connectivity systems enables disposable endoscopes to function as intelligent diagnostic instruments which speed up data based surgical choices in minimally invasive procedures. The integration of visualization platforms allows users to easily connect devices for ambulatory surgical centers and office based procedures which disrupts the established hospital based healthcare system. The ability of cloud compatible devices to enable remote review and training and quality benchmarking creates new revenue opportunities for health IT companies and virtual care providers and analytics firms. The transformation enables healthcare providers to establish uniform treatment protocols and track performance results throughout different locations of integrated delivery systems and multi site networks.